vs

Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $26.6M, roughly 1.6× NeuroPace Inc). NeuroPace Inc runs the higher net margin — -10.3% vs -1545.5%, a 1535.3% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 15.0%).

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

NFBK vs NPCE — Head-to-Head

Bigger by revenue
NFBK
NFBK
1.6× larger
NFBK
$41.3M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+11.2% gap
NPCE
23.9%
12.7%
NFBK
Higher net margin
NPCE
NPCE
1535.3% more per $
NPCE
-10.3%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$52.1M more FCF
NFBK
$52.5M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
15.0%
NFBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NFBK
NFBK
NPCE
NPCE
Revenue
$41.3M
$26.6M
Net Profit
$-27.4M
$-2.7M
Gross Margin
77.4%
Operating Margin
-1263.3%
-6.6%
Net Margin
-1545.5%
-10.3%
Revenue YoY
12.7%
23.9%
Net Profit YoY
-343.6%
48.0%
EPS (diluted)
$-0.68
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NFBK
NFBK
NPCE
NPCE
Q4 25
$41.3M
$26.6M
Q3 25
$39.2M
$27.4M
Q2 25
$38.9M
$23.5M
Q1 25
$34.8M
$22.5M
Q4 24
$36.7M
$21.5M
Q3 24
$31.8M
$21.1M
Q2 24
$31.5M
$19.3M
Q1 24
$31.3M
$18.1M
Net Profit
NFBK
NFBK
NPCE
NPCE
Q4 25
$-27.4M
$-2.7M
Q3 25
$10.8M
$-3.5M
Q2 25
$9.6M
$-8.7M
Q1 25
$7.9M
$-6.6M
Q4 24
$11.3M
$-5.3M
Q3 24
$6.5M
$-5.5M
Q2 24
$6.0M
$-7.5M
Q1 24
$6.2M
$-8.9M
Gross Margin
NFBK
NFBK
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NFBK
NFBK
NPCE
NPCE
Q4 25
-1263.3%
-6.6%
Q3 25
37.7%
-9.5%
Q2 25
35.6%
-29.0%
Q1 25
31.0%
-22.9%
Q4 24
38.0%
-17.0%
Q3 24
27.9%
-20.1%
Q2 24
29.1%
-32.4%
Q1 24
27.2%
-41.6%
Net Margin
NFBK
NFBK
NPCE
NPCE
Q4 25
-1545.5%
-10.3%
Q3 25
27.4%
-12.8%
Q2 25
24.6%
-36.8%
Q1 25
22.6%
-29.3%
Q4 24
30.7%
-24.5%
Q3 24
20.5%
-25.9%
Q2 24
18.9%
-39.0%
Q1 24
19.9%
-49.2%
EPS (diluted)
NFBK
NFBK
NPCE
NPCE
Q4 25
$-0.68
$-0.08
Q3 25
$0.27
$-0.11
Q2 25
$0.24
$-0.26
Q1 25
$0.19
$-0.21
Q4 24
$0.27
$-0.16
Q3 24
$0.16
$-0.19
Q2 24
$0.14
$-0.26
Q1 24
$0.15
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NFBK
NFBK
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$164.0M
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$690.1M
$19.0M
Total Assets
$5.8B
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NFBK
NFBK
NPCE
NPCE
Q4 25
$164.0M
$61.1M
Q3 25
$131.7M
$60.0M
Q2 25
$97.6M
$62.1M
Q1 25
$101.7M
$66.3M
Q4 24
$167.7M
$52.8M
Q3 24
$232.9M
$56.8M
Q2 24
$153.5M
$55.5M
Q1 24
$238.8M
$58.9M
Total Debt
NFBK
NFBK
NPCE
NPCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NFBK
NFBK
NPCE
NPCE
Q4 25
$690.1M
$19.0M
Q3 25
$719.6M
$18.5M
Q2 25
$710.3M
$19.4M
Q1 25
$711.1M
$24.3M
Q4 24
$704.7M
$8.0M
Q3 24
$699.6M
$9.8M
Q2 24
$693.0M
$9.9M
Q1 24
$698.4M
$14.3M
Total Assets
NFBK
NFBK
NPCE
NPCE
Q4 25
$5.8B
$105.6M
Q3 25
$5.7B
$107.3M
Q2 25
$5.7B
$106.1M
Q1 25
$5.7B
$110.2M
Q4 24
$5.7B
$94.6M
Q3 24
$5.7B
$96.3M
Q2 24
$5.7B
$94.4M
Q1 24
$5.9B
$98.9M
Debt / Equity
NFBK
NFBK
NPCE
NPCE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NFBK
NFBK
NPCE
NPCE
Operating Cash FlowLast quarter
$53.7M
$506.0K
Free Cash FlowOCF − Capex
$52.5M
$409.0K
FCF MarginFCF / Revenue
127.1%
1.5%
Capex IntensityCapex / Revenue
2.8%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$89.2M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NFBK
NFBK
NPCE
NPCE
Q4 25
$53.7M
$506.0K
Q3 25
$13.9M
$-1.9M
Q2 25
$14.1M
$-2.1M
Q1 25
$9.4M
$-7.5M
Q4 24
$31.1M
$-4.8M
Q3 24
$14.0M
$-1.7M
Q2 24
$6.9M
$-3.9M
Q1 24
$4.2M
$-7.5M
Free Cash Flow
NFBK
NFBK
NPCE
NPCE
Q4 25
$52.5M
$409.0K
Q3 25
$13.6M
$-2.0M
Q2 25
$13.9M
$-2.3M
Q1 25
$9.2M
$-7.5M
Q4 24
$30.0M
$-4.8M
Q3 24
$13.7M
$-1.8M
Q2 24
$6.7M
$-4.0M
Q1 24
$3.8M
$-7.6M
FCF Margin
NFBK
NFBK
NPCE
NPCE
Q4 25
127.1%
1.5%
Q3 25
34.6%
-7.2%
Q2 25
35.7%
-9.6%
Q1 25
26.3%
-33.4%
Q4 24
81.6%
-22.5%
Q3 24
43.2%
-8.7%
Q2 24
21.1%
-20.6%
Q1 24
12.1%
-42.1%
Capex Intensity
NFBK
NFBK
NPCE
NPCE
Q4 25
2.8%
0.4%
Q3 25
0.8%
0.1%
Q2 25
0.6%
0.7%
Q1 25
0.7%
0.2%
Q4 24
3.1%
0.2%
Q3 24
0.7%
0.5%
Q2 24
0.8%
0.3%
Q1 24
1.4%
0.6%
Cash Conversion
NFBK
NFBK
NPCE
NPCE
Q4 25
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons